| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
| mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
AUY922 |
GDSC1000 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
| mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
Bryostatin 1 |
GDSC1000 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
-0.024 |
0.9 |
| mRNA |
TL-1-85 |
GDSC1000 |
pan-cancer |
AAC |
0.0023 |
0.9 |